[Cost-effectiveness of the addition of acarbose to the treatment of patients with type-2 diabetes in Spain].
- Published Article
Gaceta sanitaria / S.E.S.P.A.S
- Publication Date
Jan 01, 2007
This long-term economic study showed that the addition of acarbose to existing therapy for DM2 was associated with improvements in life expectancy and QALYs in these patients.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/17419924